T

Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119

Watchlist Manager
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Watchlist
Price: 18.4 CNY -4.66% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Tianjin Ringpu Bio-Technology Co Ltd?
Write Note

Tianjin Ringpu Bio-Technology Co Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tianjin Ringpu Bio-Technology Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
T
Tianjin Ringpu Bio-Technology Co Ltd
SZSE:300119
Tax Provision
-ÂĄ62.6m
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
-16%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Tax Provision
-ÂĄ488.7m
CAGR 3-Years
3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Tax Provision
-ÂĄ557.5m
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
-23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Tax Provision
-ÂĄ498.4m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
-9%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Tax Provision
-ÂĄ700.5m
CAGR 3-Years
19%
CAGR 5-Years
-43%
CAGR 10-Years
-5%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Tax Provision
-ÂĄ11.5m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tianjin Ringpu Bio-Technology Co Ltd
Glance View

Market Cap
8.6B CNY
Industry
Pharmaceuticals

Tianjin Ringpu Bio-technology Co., Ltd. engages in the provision of animal health services. The company is headquartered in Tianjin, Tianjin and currently employs 2,701 full-time employees. The company went IPO on 2010-09-17. The firm operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

Intrinsic Value
24.46 CNY
Undervaluation 25%
Intrinsic Value
Price
T

See Also

What is Tianjin Ringpu Bio-Technology Co Ltd's Tax Provision?
Tax Provision
-62.6m CNY

Based on the financial report for Sep 30, 2024, Tianjin Ringpu Bio-Technology Co Ltd's Tax Provision amounts to -62.6m CNY.

What is Tianjin Ringpu Bio-Technology Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-16%

Over the last year, the Tax Provision growth was -48%. The average annual Tax Provision growth rates for Tianjin Ringpu Bio-Technology Co Ltd have been 1% over the past three years , -15% over the past five years , and -16% over the past ten years .

Back to Top